Coding Bio

Drug Discovery · Oxford, United Kingdom · Founded 2020 · Privately Held (backing)

Developer of a cell discovery platform designed to accelerate the development of new targets for chimeric antigen receptors. Coding Bio is based in Oxford, United Kingdom and was founded in 2020. It was valued at $6.6 million at its seed round in Sep 2023, the last priced event on record. It has raised $3.6 million across 1 recorded round; the latest was a $3.6 million seed round in Sep 2023.

PMV mark · valuation
$6.6M
Oct 2026
Priced at
its seed round
Sep 2023
Total raised
$3.6M
Last round
Seed Round
Sep 2023

Who backs Coding Bio?

15 investors
InvestorType
Metaplanet HoldingsVenture capital
Global Founders CapitalVenture capital
2048 VenturesVenture capital
BoxOne VenturesOther
The Venture CollectiveVenture capital
Nadav RosenbergOther
Bija Ventures—
Divergent Capital—
Divergent Capital (New York)—
Google Accelerator—
+ 5 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Coding Bio investors

15 investors are on record for Coding Bio, including Metaplanet Holdings, Global Founders Capital, 2048 Ventures and BoxOne Ventures. The seed round in Sep 2023 drew 11 investors.

Free account
More of Coding Bio with a free account
  • ·The complete investor list: 15 names
  • ·Watch Coding Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 15 firms already write checks for companies like Coding Bio in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View